Fiber shaft-chimeric adenovirus vectors lacking the KKTK motif efficiently infect liver cells in vivo

被引:34
作者
Di Paolo, Nelson C. [1 ]
Kalyuzhniy, Oleksandr [1 ]
Shayakhmetov, Dmitry M. [1 ]
机构
[1] Univ Washington, Dept Med, Div Med Genet, Seattle, WA 98195 USA
关键词
D O I
10.1128/JVI.01584-07
中图分类号
Q93 [微生物学];
学科分类号
071005 ; 100705 ;
摘要
The molecular mechanisms governing the infectivity of adenovirus (Ad) toward specific cell and tissue types in vivo remain poorly understood. The direct Ad binding to hepatic heparan sulfate proteoglycans via the KKTK motif within the fiber shaft domain was suggested to be the major mechanism of Ad liver cell infection in vivo. Here, we describe the generation and in vitro and in vivo infectivity studies of Ad5-based vectors possessing long Ad31- or Ad41-derived fiber shaft domains, which lack the KKTK motif. We found that all the critical early steps of Ad infection, including attachment to the cellular receptor, internalization, and virus genome transfer into the nucleus, occurred with similar levels of efficiency for fiber shaft-chimeric vectors and unmodified Ad5. Upon intravenous delivery into mice, fiber shaft-chimeric vectors accumulated in liver tissue, transduced liver cells, and induced the production of proinflammatory cytokines (tumor necrosis factor alpha and interleukin-6) and the chemokine monocyte chemoattractant protein 1 at levels indistinguishable from those observed for Ad5. Thus, our data provide evidence that the Ad5 fiber shaft amino acid sequence does not play any substantial role in determining adenovirus infectivity toward hepatic cells in vivo. The data obtained contribute to improving our understanding of the molecular mechanisms determining Ad infectivity and biodistribution in vivo and may aid in designing novel Ad-based vectors for gene therapy applications.
引用
收藏
页码:12249 / 12259
页数:11
相关论文
共 51 条
[1]   CAR-binding ablation does not change biodistribution and toxicity of adenoviral vectors [J].
Alemany, R ;
Curiel, DT .
GENE THERAPY, 2001, 8 (17) :1347-1353
[2]   The influence of blood on in vivo adenovirus bio-distribution and transduction [J].
Baker, Andrew H. ;
Mcvey, John H. ;
Waddington, Simon N. ;
Di Paolo, Nelson C. ;
Shayakhmetov, Dmitry M. .
MOLECULAR THERAPY, 2007, 15 (08) :1410-1416
[3]   Role of the putative heparan sulfate glycosaminoglycan-binding site of the adenovirus type 5 fiber shaft on liver detargeting and knob-mediated retargeting [J].
Bayo-Puxan, Neus ;
Cascallo, Manel ;
Gros, Alena ;
Huch, Meritxell ;
Fillat, Cristina ;
Alemany, Ramon .
JOURNAL OF GENERAL VIROLOGY, 2006, 87 :2487-2495
[4]   Isolation of a common receptor for coxsackie B viruses and adenoviruses 2 and 5 [J].
Bergelson, JM ;
Cunningham, JA ;
Droguett, G ;
KurtJones, EA ;
Krithivas, A ;
Hong, JS ;
Horwitz, MS ;
Crowell, RL ;
Finberg, RW .
SCIENCE, 1997, 275 (5304) :1320-1323
[5]   Receptors mediating adenovirus attachment and internalization [J].
Bergelson, JM .
BIOCHEMICAL PHARMACOLOGY, 1999, 57 (09) :975-979
[6]   Acute toxicity after high-dose systemic injection of helper-dependent adenoviral vectors into nonhuman primates [J].
Brunetti-Pierri, N ;
Palmer, DJ ;
Beaudet, AL ;
Carey, KD ;
Finegold, M ;
Ng, P .
HUMAN GENE THERAPY, 2004, 15 (01) :35-46
[7]   Heparan sulfate glycosaminoglycans are involved in adenovirus type 5 and 2-host cell interactions [J].
Dechecchi, MC ;
Tamanini, A ;
Bonizzato, A ;
Cabrini, G .
VIROLOGY, 2000, 268 (02) :382-390
[8]   Heparan sulfate glycosaminoglycans are receptors sufficient to mediate the initial binding of adenovirus types 2 and 5 [J].
Dechecchi, MC ;
Melotti, P ;
Bonizzato, A ;
Santacatterina, M ;
Chilosi, M ;
Cabrini, G .
JOURNAL OF VIROLOGY, 2001, 75 (18) :8772-8780
[9]   CD46 is a cellular receptor for group B adenoviruses [J].
Gaggar, A ;
Shayakhmetov, DM ;
Lieber, A .
NATURE MEDICINE, 2003, 9 (11) :1408-1412
[10]   Adenovirus infection: Taking the back roads to viral entry [J].
Goosney, DL ;
Nemerow, GR .
CURRENT BIOLOGY, 2003, 13 (03) :R99-R100